La jolla innoviva
WebJul 11, 2024 · BURLINGAME, Calif. and WALTHAM, Mass. - July 11, 2024 - Innoviva, Inc. (Nasdaq: INVA), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, and La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the commercialization of innovative therapies that improve … WebJul 11, 2024 · Innoviva, Inc. (Parent Company) Wholly owned subsidiaries: La Jolla Pharmaceutical Company & Tetraphase Pharmaceuticals, Inc.
La jolla innoviva
Did you know?
WebJul 21, 2024 · July 21, 2024 Innoviva, Inc. announced its $149 million all cash acquisition of La Jolla Pharmaceutical Company, following a wave of pharmaceutical consolidation that has swept the industry... WebAug 22, 2024 · La Jolla brings to Innoviva an established product portfolio, including GIAPREZA® (angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock and XERAVA® (eravacycline) for the treatment of complicated intra-abdominal infections (cIAIs).
WebJul 11, 2024 · La Jolla Pharmaceutical Waltham, Massachusetts, United States website La Jolla Pharmaceutical is a biotechnology company involved in the development of therapeutics for lupus nephritis and other autoimmune diseases. La Jolla Pharmaceutical was founded in 1989 and is based in Waltham, Massachusetts. Search 177,329 Deals … WebLa Jolla Pharmaceutical Company 2024 La Jolla Pharmaceutical Company La Jolla is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases
WebInnoviva’s wholly owned subsidiaries, Entasis Therapeutics Inc. and La Jolla Pharmaceutical Company, add robust scientific and commercial expertise to our healthcare portfolio. Entasis ... WebWhen La Jolla Pharmaceutical Company scored its first approval—getting septic shock treatment Giapreza across the FDA finish line in 2024—the drug was Struggling La Jolla …
WebJul 11, 2024 · InvestorPlace - Stock Market News, Stock Advice & Trading Tips In a development that’s garnering attention in the healthcare sector, La ...
WebAug 19, 2024 · Innoviva has agreed to pay $5.95 per share for La Jolla, representing a premium of approximately 70% to the 30-day volume-weighted average price (VWAP), and an incremental $0.28 per share for additional cash proceeds received in connection with the divestiture of a non-core asset. synonym technical expertiseWebJul 11, 2024 · Under the terms of the merger agreement, Innoviva, through a wholly owned subsidiary, will commence a tender offer on or before July 25, 2024 to acquire all of the … synonym thank you for your considerationWebOct 14, 2024 · WALTHAM, Mass.--(BUSINESS WIRE)--Oct 14, 2024--La Jolla Pharmaceutical Company, a wholly owned subsidiary of Innoviva, Inc. (Nasdaq: INVA) dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced that five abstracts highlighting … thalasso pieds homedics hm fs-150WebJul 11, 2024 · California-based firms Innoviva Inc. and La Jolla Pharmaceutical Company announced Monday that they had entered into a $149-million merger agreement. Under the terms of the transaction, Innoviva is set to make its tender offer to acquire all outstanding shares of La Jolla on or before July 25. synonym themenWebLa Jolla Pharmaceutical Company, a subsidiary of Innoviva, Inc., is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening... synonym thank you for your businessWebAug 22, 2024 · La Jolla brings to Innoviva an established product portfolio, including GIAPREZA® (angiotensin II), approved to increase blood pressure in adults with septic … thalassophryne nattereriWebJul 11, 2024 · Innoviva, Inc. (Nasdaq: INVA), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, and La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening … thalasso pornichet pass decouverte